On Jan. 3, 2018, The Centre for Process Innovation (CPI), announced a collaboration with GlycoSeLect UK, ForteBio Pall Life Science, and Allergan Biologics to develop a novel analytical platform to improve the rapid analysis of the glycosylation profiles of biotherapeutics.
The collaboratiOriginal Article
